Abstract:Mitochondria play important roles in maintaining cellular homeostasis and skeletal muscle health, and damage to mitochondria can lead to a series of pathophysiological changes. Mitochondrial dysfunction can lead to skeletal muscle atrophy, and its molecular mechanism leading to skeletal muscle atrophy is complex. Understanding the pathogenesis of mitochondrial dysfunction is useful for the prevention and treatment of skeletal muscle atrophy, and finding drugs and methods to target and modulate mitochondrial function are urgent tasks in the prevention and treatment of skeletal muscle atrophy. In this review, we first discussed the roles of normal mitochondria in skeletal muscle. Importantly, we described the effect of mitochondrial dysfunction on skeletal muscle atrophy and the molecular mechanisms involved. Furthermore, the regulatory roles of different signaling pathways (AMPK-SIRT1-PGC-1α, IGF-1-PI3K-Akt-mTOR, FoxOs, JAK-STAT3, TGF-β-Smad2/3 and NF-κB pathways, etc.) and the roles of mitochondrial factors were investigated in mitochondrial dysfunction. Next, we analyzed the manifestations of mitochondrial dysfunction in muscle atrophy caused by different diseases. Finally, we summarized the preventive and therapeutic effects of targeted regulation of mitochondrial function on skeletal muscle atrophy, including drug therapy, exercise and diet, gene therapy, stem cell therapy and physical therapy. This review is of great significance for the holistic understanding of the important role of mitochondria in skeletal muscle, which is helpful for researchers to further understanding the molecular regulatory mechanism of skeletal muscle atrophy, and has an important inspiring role for the development of therapeutic strategies for muscle atrophy targeting mitochondria in the future.

Mitochondrial quality control and its role in osteoporosis

Mitochondrial dysfunction and therapeutic perspectives in osteoporosis

Targeting Mitochondrial Quality Control in Muscle Aging: Natural Dietary Products As Potential Interventions

Therapeutic and tampering approaches for mitochondrial associated diseases

Mitochondrial quality control dysfunction in osteoarthritis: Mechanisms, therapeutic strategies & future prospects

Sirtuins mediate mitochondrial quality control mechanisms: a novel therapeutic target for osteoporosis

Targeting mitochondrial quality control: new therapeutic strategies for major diseases

Mitochondria: Potential Targets for Osteoarthritis

Mitochondrial dysfunction: mechanisms and advances in therapy

Mitochondrial quality control in human health and disease

Targeted Drug Delivery for Precision Mitochondrial Therapy in Osteoporosis: Therapeutic Strategies and Advances

The role of mitochondrial quality control mechanisms in chondrocyte senescence

The Role of Mitochondrial Quality Control in Chronic Obstructive Pulmonary Disease

Cell life-or-death events in osteoporosis: All roads lead to mitochondrial dynamics

Mitochondrial Quality Control in Ovarian Function: From Mechanisms to Therapeutic Strategies

Mitochondrial dysfunction: roles in skeletal muscle atrophy

Mitochondrial quality control proteases and their modulation for cancer therapy

Mitophagy: An Emerging Role in Aging and Age-Associated Diseases

Mechanisms of mitochondrial dysfunction in ovarian aging and potential interventions

Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance

Mitochondrial Quality Orchestrates Muscle-Adipose Dialog to Alleviate Dietary Obesity